QC
BHST

Quadrature Capital’s BioHarvest Sciences BHST Stock Holding History

Quadrature Capital’s Portfolio BHST Stock Details BHST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,065
Closed -$140K – 1967
2025
Q4 		$140K Buy
+27,065
New +$216K ﹤0.01% 1041

Other funds holding BHST

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
TNA
True North Advisors Dallas, Texas $1.05B AUM 22.99% 1-Year Est. Return
EWM
Evercore Wealth Management New York $7.07B AUM 24.72% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Quadrature Capital's BHST Position: Q1 2026 in Review

Quadrature Capital sold out of BioHarvest Sciences (BHST) in Q1 2026, closing a stake of 27,065 shares — an estimated $140K sold.

Quadrature Capital first reported a position in BHST in Q4 2025 and held it in 1 quarter. The position peaked at $140K in Q4 2025. 20 funds tracked by Wall St. Rank hold BHST as of Q1 2026.

  • Quadrature Capital reported no remaining BioHarvest Sciences position as of Q1 2026 after selling out during the quarter.
  • Quadrature Capital sold 27,065 BioHarvest Sciences shares in Q1 2026, an estimated $140K.
  • Quadrature Capital first reported a position in BioHarvest Sciences in Q4 2025 and held it in 1 quarter.
  • Quadrature Capital's BioHarvest Sciences position peaked at $140K in Q4 2025.
  • 20 funds tracked by Wall St. Rank held BioHarvest Sciences as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.